These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25897263)

  • 1. Patient-reported outcomes after discontinuation of long-term topical corticosteroid treatment for atopic dermatitis: a targeted cross-sectional survey.
    Takahashi-Ando N; Jones MA; Fujisawa S; Hama R
    Drug Healthc Patient Saf; 2015; 7():57-62. PubMed ID: 25897263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
    de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
    Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of atopic dermatitis managed without topical corticosteroids for a 6-month period.
    Fukaya M; Sato K; Yamada T; Sato M; Fujisawa S; Minaguchi S; Kimata H; Dozono H
    Clin Cosmet Investig Dermatol; 2016; 9():151-8. PubMed ID: 27445501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The knowledge of issues associated with topical corticosteroids using in patients with atopic dermatitis.
    Jaworek A; Szafraniec K; Pastuszczak M; Zalewski A; Wojas-Pelc A
    Pol Merkur Lekarski; 2019 Jun; 46(276):243-247. PubMed ID: 31260432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea.
    Lee JY; Her Y; Kim CW; Kim SS
    Ann Dermatol; 2015 Oct; 27(5):499-506. PubMed ID: 26512163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey.
    El Hachem M; Gesualdo F; Ricci G; Diociaiuti A; Giraldi L; Ametrano O; Occella C; Fortina AB; Milioto M; Arcangeli F; Simonetti O; Giancristoforo S; Calamelli E; Mazzatenta C; Neri I
    Ital J Pediatr; 2017 Feb; 43(1):22. PubMed ID: 28245844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross-sectional study using TOPICOP in Japan.
    Saito-Abe M; Futamura M; Yamamoto-Hanada K; Yang L; Suzuki K; Ohya Y
    Pediatr Dermatol; 2019 May; 36(3):311-316. PubMed ID: 30882946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
    Simpson EL; Flohr C; Eichenfield LF; Bieber T; Sofen H; Taïeb A; Owen R; Putnam W; Castro M; DeBusk K; Lin CY; Voulgari A; Yen K; Omachi TA
    J Am Acad Dermatol; 2018 May; 78(5):863-871.e11. PubMed ID: 29353026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Tolerability of a Medical Device Repairing Emollient Cream Associated with a Topical Corticosteroid in Adults with Atopic Dermatitis: An Open-label, Intra-individual Randomized Controlled Study.
    Rossi AB; Bacquey A; Nocera T; Thouvenin MD
    Dermatol Ther (Heidelb); 2018 Jun; 8(2):217-228. PubMed ID: 29511936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use.
    Smith SD; Farrugia LL; Harris V; Lee A; Carter SR; Blaszczynski A; Fischer G
    J Dermatolog Treat; 2017 Nov; 28(7):642-646. PubMed ID: 28349719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    Thomson J; Wernham AGH; Williams HC
    Br J Dermatol; 2018 Apr; 178(4):897-902. PubMed ID: 29315479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different potencies of topical corticosteroids for a better treatment strategy in children with atopic dermatitis (the Rotterdam Eczema study): protocol for an observational cohort study with an embedded randomised open-label controlled trial.
    van Halewijn KF; Bohnen AM; van den Berg PJ; Pasmans SGMA; Bindels PJE; Elshout G
    BMJ Open; 2019 Jun; 9(6):e027239. PubMed ID: 31221882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.
    Gonzalez ME; Schaffer JV; Orlow SJ; Gao Z; Li H; Alekseyenko AV; Blaser MJ
    J Am Acad Dermatol; 2016 Sep; 75(3):481-493.e8. PubMed ID: 27543211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study.
    Albogami MF; AlJomaie MS; Almarri SS; Al-Malki S; Tamur S; Aljaid M; Khayat A; Alzahrani A
    Patient Prefer Adherence; 2023; 17():2761-2772. PubMed ID: 37936715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
    J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary cortisol response to stress in young children with atopic dermatitis.
    Kojima R; Matsuda A; Nomura I; Matsubara O; Nonoyama S; Ohya Y; Saito H; Matsumoto K
    Pediatr Dermatol; 2013; 30(1):17-22. PubMed ID: 22612522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial comparing topical steroid application to wet versus dry skin in children with atopic dermatitis (AD).
    Kohn LL; Kang Y; Antaya RJ
    J Am Acad Dermatol; 2016 Aug; 75(2):306-11. PubMed ID: 27259583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.